Cargando...
The evolution of strategies to minimise the risk of human drug-induced liver injury (DILI) in drug discovery and development
Early identification of toxicity associated with new chemical entities (NCEs) is critical in preventing late-stage drug development attrition. Liver injury remains a leading cause of drug failures in clinical trials and post-approval withdrawals reflecting the poor translation between traditional pr...
Gardado en:
| Publicado en: | Arch Toxicol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer Berlin Heidelberg
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7395068/ https://ncbi.nlm.nih.gov/pubmed/32372214 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00204-020-02763-w |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|